WIRB Protocol No. 20021157Ohio State University
IS CURRENTLY RECRUITING PARTICIPANTS FOR A NON-DRUG RESEARCH STUDY OF A DIETARY SUPPLEMENT FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
This 8 month study is designed to examine the safety and efficacy of a dietary supplement (SH90011) in children with Attention Deficit/Hyperactivity Disorder (ADHD). The study will be using placebo (fake tablets) or dietary supplement for the first 4 months (half a chance of each), then 4 months of dietary supplement for everyone.
To be eligible for this study, participants must:
ALL EVALUATIONS AND SUPPLEMENTS FOR THIS STUDY ARE PROVIDED WITHOUT COST TO PARTICIPANTS. IN ADDITION, FAMILIES WHO PARTICIPATE IN THE FULL STUDY (5 VISITS PLUS MAILED RATING SCALES) WILL BE REIMBURSED. THERE ARE RISKS, WHICH WILL BE EXPLAINED BEFORE ANYONE AGREES TO PARTICIPATE.
- be between the ages of 5 and 10, inclusive,
- meet diagnostic criteria for attention deficit/hyperactivity disorder,
- not have a significant medical condition (e.g., heart disease, high blood pressure, lung disease, liver or kidney failure, unstable seizure disorder, thyroid disease),
- not be taking medication for ADHD at the time of study entry,
- have no plans for medication for ADHD in the next 8 months.
Jill Hollway Phone: (614) 247- 6402
Fax: (614) 247-7117
Dawn Rybarczyk Phone: (614) 688-3848
Principal Investigator: L. Eugene Arnold M.D.
Project Coordinator: Jill Hollway
Associate Project Coordinator: Dawn Rybarczyk
Co-Investigators: Ronald Lindsay, M.D., Yaser Ramadan, M.D.